Skip to main content
  • Home
  •  Prof Kausik (Kosh) Ray

Kausik (Kosh) Ray

Professor of Public Health

Imperial College London, London, UK

Biography

Kausik Ray is currently Professor of Public Health, Deputy Director of Imperial Clinical Trials Unit and Head of Commercial Trials within the Department of Public Health and Primary Care, School of Public Health, Imperial College London, Consultant Cardiologist and Chief Clinical Officer and Head of Trials – Discover Now as well as NIHR ARC National Lead of Cardiovascular Disease.

Professor Ray received his medical education (MB ChB, 1991) at the University of Birmingham Medical School, his MD (2004) at the University of Sheffield, a postdoctoral fellowship at Harvard Medical School and finally an MPhil in epidemiology (2007) from the University of Cambridge.
A Fellow of the American College of Cardiology, the European Society of Cardiology, the American Heart Association and the Royal College of Physicians, Kausik Ray is also a member of the British Cardiovascular Society and President-Elect of the European Atherosclerosis Society, also serving on the EAS Consensus panel and EAS Executive Committee. Professor Ray has either been the National Lead Investigator, Principal Investigator, or served on committees for several major medical trials, as well as international registries and is currently involved in 8 ongoing trials in lipids and diabetes and the PI for ORION 1, 3, 11 assessing PCSK9 inhibition through RNA interference and BETONMACE assessing BET protein inhibition in patients with ACS.
 

Featured Courses

Achieving Lipid Targets & Managing CV Risk: Reassessing our way with Statins
  • 1.00 EBAC

Learning objectives

  • Recall prevalence of patients who are statin uncontrolled/intolerant
  • Define the additive benefit of combination treatment compared with statin intensification
  • Name the non-statin LLTs offering proven CV protection
  • Identifying patients with indication for novel non-statin therapy
  • Initiate lipid-lowering strategies proven to lower future CV events
See more